Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ane Rivas-Macho, María V. Romeo, Elisabeth Rackles, Garbiñe Olabarria, Juan Manuel Falcon-Perez, Jesús Berganza-Granda, Aitziber L. Cortajarena & Felipe Goñi-de-Cerio. (2023) Potential use of heat shock protein 90 as a biomarker for the diagnosis of human diseases. Expert Review of Molecular Diagnostics 23:10, pages 875-884.
Read now
Read now
Articles from other publishers (17)
Manu Singhai, Ghanshyam Das Gupta, Bharat Khurana, Daisy Arora, Sumel Ashique & Neeraj Mishra. (2024) Nanotechnology-based Drug Delivery Systems for the Treatment of Cervical Cancer: A Comprehensive Review. Current Nanoscience 20:2, pages 224-247.
Crossref
Crossref
Aneta Popiel-Kopaczyk, Jedrzej Grzegrzolka, Aleksandra Piotrowska, Mateusz Olbromski, Beata Smolarz, Hanna Romanowicz, Agnieszka Rusak, Monika Mrozowska, Piotr Dziegiel, Marzenna Podhorska-Okolow & Christopher Kobierzycki. (2023) The Expression of Testin, Ki-67 and p16 in Cervical Cancer Diagnostics. Current Issues in Molecular Biology 45:1, pages 490-500.
Crossref
Crossref
E.A. Artemjeva, M.I. Pakharukova & Yu.G. Lagereva. (2023) Application of p16/Ki-67 double-stained immunohistochemistry in diagnosis of cervical intraepithelial lesions. Laboratornaya sluzhba 12:4, pages 37.
Crossref
Crossref
Ganesh Kumar Barik, Osheen Sahay, Debasish Paul & Manas Kumar Santra. (2022) Ezrin gone rogue in cancer progression and metastasis: An enticing therapeutic target. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:4, pages 188753.
Crossref
Crossref
Vinod B. Shidham. (2022) Role of immunocytochemistry in cervical cancer screening. Cytojournal 19, pages 42.
Crossref
Crossref
Laura Gilbert, Sam Ratnam, Dan Jang, Reza Alaghehbandan, Miranda Schell, Rob Needle, Anne Ecobichon-Morris, Arnav Wadhawan, Dustin Costescu, Laurie Elit, Peter Wang, George Zahariadis & Max Chernesky. (2022) Comparison of CINtec PLUS cytology and cobas HPV test for triaging Canadian patients with LSIL cytology referred to colposcopy: A two-year prospective study. Cancer Biomarkers 34:3, pages 347-358.
Crossref
Crossref
Pesona Grace Lucksom, Mingma Lhamu Sherpa, Anup Pradhan, Sunaina Lal & Chamma Gupta. (2021) Advances in HPV Screening Tests for Cervical Cancer—A Review. The Journal of Obstetrics and Gynecology of India 72:1, pages 13-18.
Crossref
Crossref
Ying Li, Yunfeng Fu, Bei Cheng, Xing Xie & Xinyu Wang. (2022) A Comparative Study on the Accuracy and Efficacy Between Dalton and CINtec® PLUS p16/Ki-67 Dual Stain in Triaging HPV-Positive Women. Frontiers in Oncology 11.
Crossref
Crossref
Zavuga Zuberi, Alex Mremi, Jaffu O. Chilongola, George Semango & Elingarami Sauli. (2021) Expression analysis of p16 and TOP2A protein biomarkers in cervical cancer lesions and their correlation with clinico-histopathological characteristics in a referral hospital, Tanzania. PLOS ONE 16:10, pages e0259096.
Crossref
Crossref
Marie-Claire Leaf, Diana Pearre, Fabio Cappuccini & Krishnansu Tewari. (2021) Lung cancer diagnosed on pap smear: A case report and review of the literature. Gynecologic Oncology Reports 36, pages 100776.
Crossref
Crossref
Saioa Mendaza, Joaquín Fernández-Irigoyen, Enrique Santamaría, Imanol Arozarena, David Guerrero-Setas, Tamara Zudaire, Rosa Guarch, August Vidal, José-Santos Salas, Xavier Matias-Guiu, Karina Ausín, Carmen Gil, Rubén Hernández-Alcoceba & Esperanza Martín-Sánchez. (2021) Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix. Cancers 13:7, pages 1739.
Crossref
Crossref
Calleb George Onyango, Lilian Ogonda, Bernard Guyah, Clement Shiluli, Gregory Ganda, Omenge Elkanah Orang’o & Kirtika Patel. (2020) Novel biomarkers with promising benefits for diagnosis of cervical neoplasia: a systematic review. Infectious Agents and Cancer 15:1.
Crossref
Crossref
G. M. Volgareva. (2020) PAPILLOMAVIRAL CARCINOGENESIS. SIGNIFICANT ACHIEVEMENTS AND SPECIFIC CHALLENGES. PART 3. THREE LEVELS OF CERVICAL CANCER PREVENTION AND TREATMENT. Russian Journal of Biotherapy 19:3, pages 6-11.
Crossref
Crossref
Brenna E. Swift, Li Wang, Nathaniel Jembere & Rachel Kupets. (2020) Risk of Recurrence After Treatment for Cervical Intraepithelial Neoplasia 3 and Adenocarcinoma In Situ of the Cervix: Recurrence of CIN 3 and AIS of Cervix. Journal of Lower Genital Tract Disease 24:3, pages 252-258.
Crossref
Crossref
Saioa Mendaza, Joaquín Fernández-Irigoyen, Enrique Santamaría, Tamara Zudaire, Rosa Guarch, David Guerrero-Setas, August Vidal, José Santos-Salas, Xavier Matias-Guiu, Karina Ausín, María José Díaz de Cerio & Esperanza Martín-Sánchez. (2020) Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix. International Journal of Molecular Sciences 21:6, pages 2125.
Crossref
Crossref
Eugenio Leonardo & Ricardo H. BardalesEugenio Leonardo & Ricardo H. Bardales. 2020. Practical Immunocytochemistry in Diagnostic Cytology. Practical Immunocytochemistry in Diagnostic Cytology
41
67
.
Songtao Han, Zhenzhen Cheng, Xiaoqun Zhao & Yanchun Huang. (2019)
Diagnostic value of heat shock protein 90
α
and squamous cell carcinoma antigen in detection of cervical cancer
. Journal of International Medical Research 47:11, pages 5518-5525.
Crossref
Crossref